MedPath

Effect of probiotics on multiple trauma patients

Phase 3
Conditions
Traumatic patients.
Unspecified multiple injuries
Registration Number
IRCT20211006052684N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients who are admitted to the intensive care unit (ICU) due to trauma
Patients older than 18 and younger than 70 years
Patients who are expected to stay in the ICU for 7 days or more

Exclusion Criteria

Patients who do not consent to participate in the study.
Patients who have absolute contraindication to enteral feeding or the use of probiotics.
Pregnant patients
Patients with an APACHE II score of more than 34 (mortality rate of 85% and higher)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quantitative C-reactive protein (QCRP). Timepoint: Before and 7 days after the beginning of intervention. Method of measurement: Laboratory Kit.;The Acute Physiology and Chronic Health Evaluation II score (APACHE II). Timepoint: Before and 7 days after the beginning of intervention. Method of measurement: Based on the APACHE II score table.;The Simplified Acute Physiology Score (SAPS II). Timepoint: Before and 7 days after the beginning of intervention. Method of measurement: Based on the SAPS II score table.;Sequential Organ Failure Assessment (SOFA). Timepoint: Before and 7 days after the beginning of intervention. Method of measurement: Based on the SOFA score table.
Secondary Outcome Measures
NameTimeMethod
28-day mortality. Timepoint: 28 days after the start of the intervention. Method of measurement: Questionnaire.;Time to discharge. Timepoint: At the time of patient discharge. Method of measurement: Total days from the start of intervention to discharge.
© Copyright 2025. All Rights Reserved by MedPath